More News: FDA approves Zydelig for three blood cancers.
View web version
Viewpoint
Topical Gel May Be as Effective as Oral Tamoxifen in DCIS
By

A topical gel containing an active metabolite of tamoxifen suppressed cell proliferation equally as well as the oral form.

Latest News
FDA Approves Zydelig for Three Hematologic Cancers
Eyelid Melanoma May Require More Than One Excision
Tumor Promoter Expression May Aid in Lung Cancer Diagnosis
Analysis Reveals Two Possible Intestinal Neuroendocrine Tumor Subtypes

For more on the latest research and developments in oncology, visit our News section.

Want to receive emails specific to your profession and specialty? Click here to complete your profile.





Subscribe
If you were sent this by a colleague and wish to subscribe to Weekly highlights, please click here.

Unsubscribe
To unsubscribe from the Weekly Highlights click here.
To manage your entire Cancer Therapy Advisor profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All Cancer Therapy Advisor newsletters are sent from the domain "email.cancertherapyadvisor.com". When configuring e-mail or spam filter rules, please use this domain name.

Haymarket Media Inc
114 West 26th St 4th floor
New York, NY 10001